Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Paediatr Anaesth ; 31(5): 613-615, 2021 05.
Article in English | MEDLINE | ID: mdl-33570775

ABSTRACT

A 4-day-old, 3.3 kg infant presented with suspected intestinal malrotation, necessitating emergent diagnostic laparoscopy. Intra-operatively, the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) came back positive. This is the first case report of emergency surgery and anesthesia in a positive SARS-CoV-2 newborn. This report highlights a neonate with an incidental positive SARS-CoV-2 test, no known exposure history, negative polymerase chain reaction maternal testing, and absence of respiratory symptoms who required modified pressure control ventilation settings to adequately ventilate with the high-efficiency particulate air filter in situ.


Subject(s)
COVID-19 Testing/methods , COVID-19/diagnosis , Digestive System Abnormalities/surgery , Intestinal Volvulus/surgery , SARS-CoV-2 , Humans , Infant, Newborn
2.
Pediatr Infect Dis J ; 40(3): e106-e110, 2021 03 01.
Article in English | MEDLINE | ID: mdl-33165279

ABSTRACT

BACKGROUND: Early diagnosis of HIV infection improves patient outcomes and reduces transmission. Adolescents make up one-fifth of new HIV diagnoses in the United States. We sought to quantify the number of missed opportunity encounters (MOEs) before HIV diagnosis for adolescents at a pediatric hospital (PediHosp) and a proximate adult hospital which employs universal HIV screening in its emergency department (ED) (CountyHosp). METHODS: An observational study at 2 academic tertiary care hospitals in the United States that included all adolescents 13-20 years old with a new diagnosis of behaviorally-acquired HIV infection from 2006 to 2017. MOE were defined as any encounter at PediHosp or CountyHosp after the latter of the individual's 13th birthday or the date 3 months after the individual's most recent negative HIV screen, and before the encounter of HIV diagnosis. Comparisons were made by site of diagnosis and location of MOE. RESULTS: Two-hundred five subjects met inclusion criteria: 68% male, 76% Black and 81% men who have sex with men. There were 264 MOE, the proportion of adolescent ED encounters that were MOE at the PediHosp ED was 8.3 MOE per 10,000 encounters and the proportion at the CountyHosp ED was 1.2 (relative risk = 6.7; 95% CI: 4.1-11.0; P < 0.001). CONCLUSIONS: MOE for HIV diagnosis in adolescents occur frequently and are greater in number at a PediHosp as compared with a similar adult setting with universal screening. Universal HIV screening protocols at PediHosp may identify HIV-positive adolescents earlier.


Subject(s)
Early Diagnosis , HIV Infections/diagnosis , HIV-1 , Adolescent , Female , HIV Infections/epidemiology , Humans , Male , Retrospective Studies , Texas/epidemiology , United States/epidemiology , Young Adult
3.
Pediatr Infect Dis J ; 39(9): e265-e267, 2020 09.
Article in English | MEDLINE | ID: mdl-32658097

ABSTRACT

We present a preterm infant who developed a fever and mild respiratory disease on the second day of life. Infant severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) nasopharyngeal testing was positive at 24 and 48 hours of life. Placenta histopathology revealed SARS-CoV-2 infection by electron microscopy and immunohistochemistry. Further understanding of the risk factors that lead to in utero transmission of SARS-CoV-2 infection is needed.


Subject(s)
Coronavirus Infections/transmission , Infant, Premature , Infectious Disease Transmission, Vertical , Pneumonia, Viral/transmission , Pregnancy Complications, Infectious/virology , Adult , Betacoronavirus/isolation & purification , COVID-19 , Coronavirus Infections/virology , Female , Fever/virology , Humans , Infant, Newborn , Pandemics , Placenta/pathology , Pneumonia, Viral/virology , Pregnancy , Pregnancy Complications, Infectious/diagnosis , Risk Factors , SARS-CoV-2
4.
J Pediatr Hematol Oncol ; 42(5): e365-e368, 2020 07.
Article in English | MEDLINE | ID: mdl-31033783

ABSTRACT

Leukemia-predisposing conditions, such as GATA2 haploinsufficiency, are known for their high penetrance and expressivity profiles. These disorders pose a difficult diagnostic challenge to even the most experienced clinician when they first present. We describe the case of a 17-year-old male presenting with features of nontuberculous mycobacterial infection, pulmonary fibrinoid granulomatous vasculitis, and myelodysplasia in the setting of a pathogenic GATA2 frameshift mutation confirmed by next-generation sequencing. The broad differential for GATA2 haploinsufficiency requires prompt recognition of key clinical features and laboratory abnormalities towards directing diagnosis and guiding appropriate and perhaps life-saving therapy.


Subject(s)
Fever of Unknown Origin/complications , Frameshift Mutation , GATA2 Deficiency/complications , GATA2 Transcription Factor/genetics , Haploinsufficiency , Myelodysplastic Syndromes/pathology , Adolescent , Female , Fever of Unknown Origin/genetics , GATA2 Deficiency/genetics , Humans , Myelodysplastic Syndromes/etiology , Prognosis
5.
Infect Immun ; 83(1): 146-60, 2015 Jan.
Article in English | MEDLINE | ID: mdl-25312959

ABSTRACT

There are a paucity of data concerning gene products that could contribute to the ability of Moraxella catarrhalis to colonize the human nasopharynx. Inactivation of a gene (mesR) encoding a predicted response regulator of a two-component signal transduction system in M. catarrhalis yielded a mutant unable to grow in liquid media. This mesR mutant also exhibited increased sensitivity to certain stressors, including polymyxin B, SDS, and hydrogen peroxide. Inactivation of the gene (mesS) encoding the predicted cognate sensor (histidine) kinase yielded a mutant with the same inability to grow in liquid media as the mesR mutant. DNA microarray and real-time reverse transcriptase PCR analyses indicated that several genes previously shown to be involved in the ability of M. catarrhalis to persist in the chinchilla nasopharynx were upregulated in the mesR mutant. Two other open reading frames upregulated in the mesR mutant were shown to encode small proteins (LipA and LipB) that had amino acid sequence homology to bacterial adhesins and structural homology to bacterial lysozyme inhibitors. Inactivation of both lipA and lipB did not affect the ability of M. catarrhalis O35E to attach to a human bronchial epithelial cell line in vitro. Purified recombinant LipA and LipB fusion proteins were each shown to inhibit human lysozyme activity in vitro and in saliva. A lipA lipB deletion mutant was more sensitive than the wild-type parent strain to killing by human lysozyme in the presence of human apolactoferrin. This is the first report of the production of lysozyme inhibitors by M. catarrhalis.


Subject(s)
Moraxella catarrhalis/growth & development , Moraxella catarrhalis/metabolism , Muramidase/antagonists & inhibitors , Protein Kinases/metabolism , Signal Transduction , Transcription Factors/metabolism , Cell Adhesion , Cell Line , Culture Media/chemistry , Epithelial Cells/microbiology , Gene Deletion , Gene Expression Profiling , Genetic Complementation Test , Histidine Kinase , Microarray Analysis , Protein Kinases/genetics , Real-Time Polymerase Chain Reaction , Reverse Transcriptase Polymerase Chain Reaction , Saliva/immunology , Saliva/microbiology , Transcription Factors/genetics
6.
Infect Immun ; 82(6): 2287-99, 2014 Jun.
Article in English | MEDLINE | ID: mdl-24643539

ABSTRACT

Colonization of the human nasopharynx by Moraxella catarrhalis is presumed to involve attachment of this bacterium to the mucosa. DNA microarray analysis was used to determine whether attachment of M. catarrhalis to human bronchial epithelial (HBE) cells in vitro affected gene expression in this bacterium. Attachment affected expression of at least 454 different genes, with 163 being upregulated and 291 being downregulated. Among the upregulated genes was one (ORF113) previously annotated as encoding a protein with some similarity to outer membrane protein A (OmpA). The protein encoded by ORF113 was predicted to have a signal peptidase II cleavage site, and globomycin inhibition experiments confirmed that this protein was indeed a lipoprotein. The ORF113 protein also contained a predicted peptidoglycan-binding domain in its C-terminal half. The use of mutant and recombinant M. catarrhalis strains confirmed that the ORF113 protein was present in outer membrane preparations, and this protein was also shown to be at least partially exposed on the bacterial cell surface. A mutant unable to produce the ORF113 protein showed little or no change in its growth rate in vitro, in its ability to attach to HBE cells in vitro, or in its autoagglutination characteristics, but it did exhibit a reduced ability to survive in the chinchilla nasopharynx. This is the first report of a lipoprotein essential to the ability of M. catarrhalis to persist in an animal model.


Subject(s)
Bacterial Outer Membrane Proteins/physiology , Moraxella catarrhalis/pathogenicity , Moraxellaceae Infections/microbiology , Nasopharyngeal Diseases/microbiology , Animals , Bacterial Adhesion/physiology , Cell Line , Chinchilla , Disease Models, Animal , Gene Expression Profiling , Gene Expression Regulation, Bacterial , Humans , Membrane Proteins/metabolism , Microbial Sensitivity Tests , Moraxella catarrhalis/drug effects , Moraxella catarrhalis/genetics , Oligonucleotide Array Sequence Analysis , Peptides/pharmacology , Protease Inhibitors/pharmacology
7.
Plasmid ; 69(2): 180-5, 2013 Mar.
Article in English | MEDLINE | ID: mdl-23219721

ABSTRACT

The lack of a transcriptional reporter system for use in Moraxella catarrhalis has hindered studies of gene regulation in this pathogen. PCR and recombinant DNA methods were used to insert a multicloning site (MCS) and promoterless full-length Escherichia coli lacZ gene, flanked by transcriptional terminators both immediately upstream and downstream, into the M. catarrhalis recombinant plasmid pWW115. Insertion into the MCS in the newly constructed plasmid pASE222 of M. catarrhalis promoter regions controlled by either a repressor (i.e., NsrR) or activator (i.e., PhoB) yielded transcriptional fusion constructs that were appropriately responsive to signal inputs dependent on the host strain genotype, as measured quantitatively by means of a Miller ß-galactosidase assay. The transcriptional reporter plasmid pASE222 should prove to be a useful tool for rapid screening of factors affecting gene expression in M. catarrhalis.


Subject(s)
Genes, Reporter , Lac Operon/genetics , Moraxella catarrhalis/genetics , Transcription, Genetic , Base Sequence , Escherichia coli/enzymology , Escherichia coli/genetics , Molecular Sequence Data , Moraxella catarrhalis/drug effects , Phosphates/pharmacology , Plasmids/genetics , Promoter Regions, Genetic/genetics , Transcription, Genetic/drug effects
SELECTION OF CITATIONS
SEARCH DETAIL
...